ROCHESTER, Minn., Oct 21, 2011 (BUSINESS WIRE) -- The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, ... Mayo Clinic Study: PSA Test Valuable in Predicting Biopsy Need, Low-Risk ...
Friday, October 21, 2011
Mayo Clinic Study: PSA Test Valuable in Predicting Biopsy Need, Low-Risk ...
ROCHESTER, Minn., Oct 21, 2011 (BUSINESS WIRE) -- The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, ... Mayo Clinic Study: PSA Test Valuable in Predicting Biopsy Need, Low-Risk ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment